Korean J Med.  2018 Apr;93(2):133-139. 10.3904/kjm.2018.93.2.133.

2018 Korean Heart Rhythm Society Guidelines for The Rate Control of Atrial Fibrillation

• Lim WH
• Choi EK
• Joung B
• Choi KJ

• KMID: 2435177
• DOI: http://doi.org/10.3904/kjm.2018.93.2.133

Abstract

Atrial fibrillation (AF) is characterized by irregular and relatively rapid heart rate, which occasionally causes symptoms such as palpitations, dyspnea, or reduced exercise capacity. Controlling the ventricular rate is a mainstay for the symptom management of patients with AF. Rate control can be achieved with beta-blockers, non-dihydropyridine calcium channel blockers, digoxin, or combination therapy. Rhythm control is an option for patients in whom appropriate rate control cannot be achieved or who have persistent symptoms despite rate control. The choices of drug and target heart rate are usually specified by international guidelines for AF management. However, pivotal trials included in those guidelines enrolled only a small number of Asian subjects, which limit application of those guidelines to a Korean population. The Korean Heart Rhythm Society organized the Korean AF Management Guideline Committee and analyzed all available studies regarding management of AF including studies with Korean patients. Then, expert consensus or guidelines for optimal management in Korean patients with AF were achieved after systematic review with intensive discussion. This article provides general principles for rate control therapy in Korean patients with AF.

Keyword

Atrial fibrillation; Heart rate; Practice guideline

MeSH Terms

Asian Continental Ancestry Group
Atrial Fibrillation*
Calcium Channel Blockers
Consensus
Digoxin
Dyspnea
Heart Rate
Heart*
Humans
Calcium Channel Blockers
Digoxin